Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) Assets Average (2016 - 2025)

Dare Bioscience (DARE) has disclosed Assets Average for 10 consecutive years, with $21.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Assets Average rose 4.95% year-over-year to $21.9 million, compared with a TTM value of $21.9 million through Sep 2025, up 4.95%, and an annual FY2024 reading of $21.7 million, down 33.37% over the prior year.
  • Assets Average was $21.9 million for Q3 2025 at Dare Bioscience, up from $15.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $52.5 million in Q1 2022 and bottomed at $9.0 million in Q1 2021.
  • Average Assets Average over 5 years is $29.1 million, with a median of $23.2 million recorded in 2023.
  • The sharpest move saw Assets Average skyrocketed 587.72% in 2021, then plummeted 53.78% in 2024.
  • Year by year, Assets Average stood at $52.3 million in 2021, then dropped by 9.96% to $47.1 million in 2022, then tumbled by 50.81% to $23.2 million in 2023, then dropped by 13.33% to $20.1 million in 2024, then rose by 8.88% to $21.9 million in 2025.
  • Business Quant data shows Assets Average for DARE at $21.9 million in Q3 2025, $15.8 million in Q2 2025, and $20.4 million in Q1 2025.